Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

@article{Snchez1999ComparisonOT,
  title={Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding},
  author={Connie S{\'a}nchez and John Hyttel},
  journal={Cellular and Molecular Neurobiology},
  year={1999},
  volume={19},
  pages={467-489}
}
Abstract1. The present survey compares the effects of antidepressants and their principal metabolites on reuptake of biogenic amines and on receptor binding. The following antidepressants were included in the study: the tricyclic antidepressants amitriptyline, dothiepin, and lofepramine and the atypical antidepressant bupropion, which all have considerable market shares in the UK and/or US markets; the selective serotonin reuptake inhibitors (SSRIs) citalopram, fluoxetine, fluvoxamine… 

Selective Serotonin Reuptake Inhibitors Potentiate the Rapid Antidepressant-Like Effects of Serotonin4 Receptor Agonists in the Rat

In acute conditions, the 5-HT4 agonist prucalopride was able to counteract the inhibitory effect of the selective serotonin reuptake inhibitors (SSRI) fluvoxamine and citalopram on 5- HT neuron impulse flow, in Dorsal Raphé Nucleus cells selected for their high basal discharge.

Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex

Results do not support the hypothesis that compared to SSRIs, compounds which inhibit both 5-HT and noradrenaline reuptake have a larger acute effect on extracellular 5- HT, and the effects of acute systemic administration of several SNRIs andSSRIs are compared.

Dual serotonin and noradrenaline uptake inhibitor class of antidepressants potential for greater efficacy or just hype?

  • D. WongF. Bymaster
  • Psychology, Biology
    Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
  • 2002
Comparative trials of dual uptake inhibitors against the other agents are needed to establish whether the dual uptake inhibitor show improvement in efficacy, rate of responders, antidepressive effects and/or remission.

Tricyclic antidepressant pharmacology and therapeutic drug interactions updated

  • P. Gillman
  • Biology, Psychology
    British journal of pharmacology
  • 2007
New data on the pharmacology of tricyclic antidepressants (TCAs), their affinities for human cloned CNS receptors and their cytochrome P450 enzyme inhibition profiles, allow improved deductions

Effect of selected antidepressant drugs on cytochrome P450 2B (CYP2B) in rat liver. An in vitro and in vivo study.

Two different mechanisms of the antidepressant-CYP2B interaction are postulated: a direct inhibition of CYP2B shown in vitro by nefazodone, SSRIs and TADs and in vivo induction of CYp2B produced by prolonged administration of SSR Is and desipramine, which suggests their influence on enzyme regulation.

Tolerability and safety of fluvoxamine and other antidepressants

Although the literature suggests that there are no clinically significant differences in efficacy amongst SSRIs, treatment decisions need to be based on considerations such as patient acceptability, response history and toxicity.

Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview

Primary properties of the SSRIs may contribute to the differences in efficacy and tolerability between members of the class, and for example, fluvoxamine has affinity for σ1‐receptors – a property likely to be responsible for its particular efficacy in delusional depression.

Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms

It is shown that the metabolite des methylcitalopram accumulates in the brain and that the metabolites desmethylcitalsertraline, norfluoxetine, and desvenlafaxine inhibit serotonin uptake in wild-type mSERT at potencies similar to those of their parent compounds, suggesting that metabolites may play a role in effects observed following AD administration inWild-type and M172 mice.

Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors

A crucial role played by the 5- HT1A receptors is suggested in balancing the reuptake inhibitory efficacy for the enhancement of 5-HT and DA transmission in the PFC by the drugs combining the reptake inhibition of all three monoamines.
...

References

SHOWING 1-10 OF 73 REFERENCES

Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor

Evidence is provided that fluoxETine, norfluoxetine and citalopram, along with many other antidepressant compounds, interact directly with the 5-HT2C receptor.

Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)

  • J. Hyttel
  • Psychology, Biology
    International clinical psychopharmacology
  • 1994
Since the marketed SSRIs all show clear antidepressant effect, this receptor regulation seems not to be a prerequisite for clinical antidepressant activity.

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

  • J. Hyttel
  • Chemistry, Psychology
    Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 1982

Comparison of norfluoxetine enantiomers as serotonin uptake inhibitors in vivo

Pharmacokinetic Optimisation of Therapy with Newer Antidepressants

  • P. Goodnick
  • Medicine, Biology
    Clinical pharmacokinetics
  • 1994
The antidepressants best suited for pharmacokinetic optimisation of therapy are the following: desipramine, sertraline, fluvoxamine, citalopram and amfebutamone, which stands out as having the best effects on behaviour among all antidepressants.

Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone

The similar reduction in the Bmax values of 3H-ketanserin binding following chronic treatment with the rapidly Dissociating setoperone and the slowly dissociating ritanserin suggest that real serotonin-S2 receptor down regulation occurs following antagonist treatment.

Effect of antidepressants on striatal and accumbens extracellular dopamine levels.

...